| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 15.11M | — |
| Operating expense | — | — |
| Net income | 1.87M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACIU returned +34.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.6% |
| 1 year | +34.9% |
| 5 years | -64.3% |
| All-time high | $16.47 (Sep 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ACIU would be worth today ›No. AC Immune SA has not paid a dividend in the past 12 months.
AC Immune SA stock trades on NASDAQ under the ticker symbol ACIU.
AC Immune SA is part of the Healthcare sector.
AC Immune SA has a market cap of 288.34M USD, based on the latest quote.
AC Immune SA is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
